“A” represents activities of daily living (ADL).

“B” represents behavior.

“C” represents cognition.

Activities of daily living are impaired in patients with Alzheimer’s disease. Tests of ADL measure the ability to handle money, to tell time, to use a phone, to dress properly, and to enjoy hobbies as well as measuring use of table manners, forgetfulness, confusion, and the needless rearrangement of objects.

Behavior is abnormal in moderate to severe stages of Alzheimer’s disease; motor restlessness, verbal and physical aggression, irritability, dysphoria, delusions, hallucinations, and sleep disturbances may occur.

Cognition is one of the first areas impaired. It includes memory deficits and language impairment.

This module will address the effects of cholinesterase inhibitors on cognition scales in controlled trials designed to assess the efficacy of these drugs in AD. The participant is encouraged to review these trials to find information of these drugs on functional and neuropsychiatric domains.